🔎 Trials Near Me

Akèy › Twoub Defisi Atansyon ak Ipèaktivite › Tennessee

Etid klinik pou Twoub Defisi Atansyon ak Ipèaktivite nan Tennessee

4 etid pou Twoub Defisi Atansyon ak Ipèaktivite ap chèche patisipan nan sit nan Tennessee.

Vil nan Tennessee

Tèks ofisyèl etid la (Anglè)

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD

  • Clinical Neuroscience Solutions, Inc., Memphis
Ap rekriteFaz 4
48 Months – 69 Months · Tout sèks · Mizajou Sep 11, 2026 · NCT04781140

Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease

  • St. Jude Children's Research Hospital, Memphis
Ap rekriteFaz 1
Laj 8 a 17 · Tout sèks · Mizajou Sep 9, 2026 · NCT07226219

Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)

  • Clinical Research Site, Memphis
Ap rekriteFaz 3
Laj 12 a 17 · Tout sèks · Mizajou Sep 8, 2026 · NCT07717892

Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)

  • Clinical Research Site, Memphis
Ap rekriteFaz 3
Laj 6 a 11 · Tout sèks · Mizajou Sep 8, 2026 · NCT07717879

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.